Stock Events

Stock Events

Cns Pharmaceuticals (BE50.F) Q3 2025 Earnings

14AugConfirmed

Q1 1

Q2 2025

Q3 2025

-21.45

-15.58

-9.72

-3.86

Details

Expected EPS

-8.240256

Actual EPS

-5.5106712

Surprise EPS

2.73

Surprise Percent

+33.13%

Description

Cns Pharmaceuticals (BE50.F) has reported earnings of -5.5106712 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.